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Selective DNAM-1 expression on 
small peritoneal macrophages 
contributes to CD4+ T cell 
costimulation
Eri Takenaka1, Anh Van Vo1,2, Yumi Yamashita-Kanemaru1, Akira Shibuya1,3 & Kazuko Shibuya1
Mouse peritoneal macrophages consist of two subsets: large peritoneal macrophages (LPMs) and small 
peritoneal macrophages (SPMs), defined as CD11bhiF4/80hi and CD11b+F4/80lo cells, respectively. We 
reveal that SPMs, but not LPMs, have the ability to present antigens to naïve CD4+ T cells. Coculture 
of SPMs with naïve ovalbumin (OVA) specific CD4+ T cells (OT-II) in the presence of OVA peptide 
effectively induced CD4+ T cells priming. SPMs, but not LPMs, strongly express DNAM-1, an activating 
immunoreceptor. Although antigen uptake and processing were comparable between WT and DNAM-
1-deficient SPMs, deficiency of DNAM-1 on SPMs or blockade of DNAM-1 and its ligand interaction 
impaired CD4+ T cells priming by SPMs. Furthermore, T and B cell responses in mediastinal lymph nodes 
of mice intraperitoneally immunized with trinitrophenyl (TNP)–OVA protein in Alum adjuvant were 
enhanced by intraperitoneally transferred wild-type, but not DNAM-1-deficient, SPMs. We propose 
that SPMs are functionally distinct from LPMs, and DNAM-1 plays a costimulatory role in antigen 
presentation by SPMs.
In the past decade, the importance of distinguishing heterogeneous populations of tissue macrophages on the 
basis of surface molecules and functions has been recognized1,2. In the mouse peritoneal cavity, macrophages are 
divided into two distinct subsets named large peritoneal macrophages (LPMs) and small peritoneal macrophages 
(SPMs)3. LPMs, which are defined as CD11bhiF4/80hi and express low levels of MHC class II (MHCII), are an 
abundant macrophage subset and likely correspond to the typically characterized peritoneal macrophages, which 
express CD11b and F4/80. In contrast, SPMs, which are defined as CD11b+F4/80lo and express high levels of 
MHCII, are a newly determined minor subset. LPMs and SPMs respectively account for >90% and approximately 
3.5%–10% of peritoneal macrophages in a variety of mouse strains, including BALB/c and C57BL/63. LPMs are 
suggested to be derived from yolk sac independently of hematopoiesis and to be maintained by self-renewal4–6; 
in addition, some reports have described the coexistence of a demand-driven replenishment pathway for LPMs 
from hematopoietic progenitors6,7. SPMs appear to be sustained through hematopoiesis, and are likely derived 
from inflammatory monocytes7,8. After inflammatory stimulation, inflammatory monocytes infiltrate into the 
peritoneal cavity and may differentiate into SPMs3.
Both SPMs and LPMs show phagocytic ability; however, phagocytic activity against bacteria3 and zymosan9 
is higher in SPMs than LPMs, whereas phagocytic activity against apoptotic cells is lower in SPMs than LPMs7. 
LPMs produce abundant G-CSF, GM-CSF, and CXCL1 after in vitro LPS stimulation7, and they produce nitric 
oxide (NO) in response to LPS both in vitro and in vivo (1). A recent report showed that LPMs induce IgA pro-
duction by B-1 cells through GATA6-dependent TGF-β production8. On the other hand, SPMs produce greater 
amounts of MIP-1α (CCL3) and TNFα than do LPMs in response to in vitro LPS stimulation7. SPMs produce NO 
after in vivo LPS stimulation, but not after in vitro LPS stimulation3. Data from the work of Cassado et al. suggest 
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that SPMs also produce NO and IL-12 after infectious stimulation with Trypanosoma cruzi9. However, little else is 
known about the physiological functions of SPMs and the functional molecules in SPMs remain unclear.
The DNAX accessory molecule-1 (DNAM-1, also known as CD226) is a member of the immunoglobulin 
superfamily and is constitutively expressed on the majority of NK cells, CD8+ T cells, CD4+ T cells, monocytes, 
and platelets in both human and mouse10,11. CD155 (also known as poliovirus receptor [PVR], Necl-5, Tage4) 
and CD112 (also known as PRR-2 or nectin-2) are ligands for human and mouse DNAM-111–13. CD155 and 
CD112 are broadly expressed on hematopoietic, epithelial, and endothelial cells in many tissues in human and 
mouse13–15. Interactions between DNAM-1 on NK cells or CD8+ T cells and CD155 or CD112 on target cells 
enhances cell-mediated cytotoxicity against target cells and cytokine production12,13,16–19; however, the expression 
profile and function of DNAM-1 on macrophages remain unclear.
Here, we investigated the functional difference between SPMs and LPMs and revealed that SPMs, but not 
LPMs, have the ability to present antigens to naïve CD4+ T cells. We further explored that DNAM-1 is highly 
expressed on SPMs, but not LPMs and play a costimulatory role in antigen presentation to CD4+ T cells by SPMs.
Results
SPMs have the ability to prime antigen specific CD4+ T cells. To investigate the antigen present-
ing ability of SPMs and LPMs in vitro, peritoneal cavity cells were collected from naïve C57BL/6 mice. CD3+ 
T cells, CD19+ B cells, CD11c+ dendritic cells (DCs), Ly6G+ neutrophils, and CD11bloSSChi eosinophils were 
excluded, and then CD11b+ macrophages were identified. Among these macrophages, CD11b+F4/80lo SPMs 
and CD11bhiF4/80hi LPMs were distinguished (Fig. 1A) and separately sorted with purity more than 90% 
(Fig. 1B). CD4+CD62LhiCD44dull naïve T cells isolated from OT-II Tg mice were labeled with carboxyfluorescein 
Figure 1. SPMs have the ability to present antigen to naïve CD4+ T cells. (A) Gating strategy of SPMs 
(CD11b+F4/80−) and LPMs (CD11bhiF4/80hi) in peritoneal cavity cells from naïve C57BL/6 mice. CD3+ T cells, 
CD19+ B cells, CD11c+ dendritic cells (DCs), Ly6G+ neutrophils, and CD11bloSSChi eosinophils were excluded, 
and SPMs and LPMs were distinguished. Numbers indicate percentage of the total population in each region. 
(B) Sorting purity of SPMs (upper panel) and LPMs (lower panel). (C, D) CD62LhiCD44dull CD4+ naïve T 
cells isolated from OT-II Tg mice were labeled with carboxyfluorescein succinimidyl ester (CFSE); and 2 × 104 
cells were cocultured with same number of SPMs or LPMs isolated from peritoneal cells of naïve mice, in the 
presence of pOVA at indicated doses. On day 5, the proliferation of CD11b negative-gated T cells was assessed 
by flow cytometry analysis of CFSE dilution. Histograms show representative data after culture with or without 
1 µM pOVA (C). Bar graph shows the average of three wells for each of the indicated pOVA concentrations (D); 
error bars indicate SEM. *P < 0.05. Data is representative of two independent experiments.
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succinimidyl ester (CFSE) to observe T cells proliferation. After the coculture of T cells with SPMs loaded with 
1 µM of pOVA for 5 days, approximately 30% of T cells proliferated (Fig. 1C). The percentages of proliferated T 
cells were dependent on the concentration of pOVA (Fig. 1D). By contrast, T cells did not proliferate after cocul-
ture with LPMs loaded with any of the doses of pOVA examined (Fig. 1C,D). These results indicate that SPMs 
have ability to prime naïve CD4+ T cells.
DNAM-1 is strongly expressed on SPMs. To find functional molecules on SPMs, we compared 
gene expression between the mouse peritoneal macrophage subsets CD115+B220−MHCII+F4/80lo cells and 
CD115+B220−MHCII−F4/80hi cells by using the microarray data of the Immunological Genome (Immgen) 
Project20, (http://www.immgen.org); the definitions of these subsets share similar features with the definitions of 
SPM and LPM, respectively3. Expression of the Cd226 gene in MHCII+F4/80lo cells was 58 times more than that 
in MHCII−F4/80hi cells (Immgen Population Comparison; MF_II + 480lo_PC vs. MF_II-480hi_PC). In addition, 
analysis using the Gene Skyline browser of Immgen revealed that Cd226 gene expression was especially high 
in MHCII+F4/80lo cells compared with other macrophage subsets, monocytes, and neutrophils (Immgen Gene 
Skyline; gene symbol = Cd226). Although the definitions of the above mouse peritoneal macrophage subsets 
share similar features with the definitions of SPM and LPM, there are several differences between them, among 
which the most important is the exclusion of CD11c+ cells in the definition of SPMs. Therefore, we examined 
DNAM-1 expression on SPMs and LPMs; we found that DNAM-1 protein was strongly expressed on SPMs, but 
not on LPMs (Fig. 2A). However, the proportions of SPM in wild-type (WT) and DNAM-1-deficient (Cd226−/−) 
mice were comparable (Supplementary Fig. 1A). CD11c+ peritoneal DCs also express DNAM-1, but at a medium 
level compared to SPMs (data not shown). Thus, we revealed uniquely high expression of DNAM-1 on SPMs.
Consistent with previous reports3, SPMs expressed higher levels of MHCII than did LPMs (Fig. 2B). The 
expression levels of both MHCII molecules and costimulatory molecules were comparable between WT mice 
and Cd226−/− mice (Fig. 2B), indicating that DNAM-1 had no effect on expression levels of either MHCII or 
costimulatory molecules.
DNAM-1–CD155 interaction is involved in costimulation of CD4+ T cells. Since SPMs are able to 
prime naïve CD4+ T cells, we examined whether DNAM-1 on SPM is involved in this function. We first com-
pared the CD4+ T cells priming abilities of SPMs isolated from WT mice and Cd226−/− mice. The frequency of 
proliferated T cells after coculture with pOVA–loaded Cd226−/− SPMs was significantly lower than that with WT 
SPMs (Fig. 3A,B), suggesting that DNAM-1 is involved in T cell priming by SPMs. We next examined whether 
DNAM-1 is involved in antigen uptake or processing by SPMs; however, both genotypes of SPMs showed compa-
rable levels of phagocytosis and antigen processing (Supplementary Fig. 1B,C).
Because we previously reported that CD155, a DNAM-1 ligand, on CD4+ T cells plays an important role in 
costimulation of T cells and promote Th1 differentiation independent of IL-1221, we supposed the ligation of 
DNAM-1 on SPMs with CD155 on T cells induces T cells proliferation. Then, we compared the T cells responses 
primed by SPMs in the presence of anti-CD155 Ab, anti-DNAM-1 neutralizing Ab or isotype-matched control 
Ab. The frequency of T cells proliferation was impaired after either coculture of anti-DNAM-1 Ab-pretreated 
SPMs with CD4+ T cells or SPMs with anti-CD155 Ab-pretreated CD4+ T cells compared to isotype control 
(Fig. 3C,D). These results indicate that the interaction between DNAM-1 on SPMs and its ligand CD155 on T 
cells is indispensable for the function of DNAM-1 in SPM-mediated antigen specific T cells priming.
Next, we examined cytokine production from CD4+ T cells after being primed by SPMs from WT mice or 
Cd226−/− mice. The frequency of IFNγ+ CD4+ T cells after coculture naïve CD4+ T with pOVA–loaded Cd226−/− 
SPMs was significantly lower than that with WT SPMs, while frequency of IL-4+ and IL-17+ CD4+ T cells were 
compatible (Fig. 3E). On the other hand, IL-12 production was compatible between WT and Cd226−/− SPMs 
Figure 2. DNAM-1 (CD226) is strongly expressed on SPMs. (A) DNAM-1 expression on SPMs and LPMs 
detected by anti-DNAM-1 mAb. (B) Expression of costimulatory molecules involved in antigen presentation on 
WT SPMs, Cd226−/− SPMs and LPMs. Open histograms indicate specific mAb and shaded histograms indicate 
isotype controls. Data is representative of over two independent experiments.
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(Supplementary Fig. 1D), indicating that the reduced IFNγ production from Cd226−/− CD4+ T cells is inde-
pendent of IL-12 production from SPMs. These results indicate that SPMs activate naïve CD4+ T cells and then 
promote Th1 differentiation in the dependence on costimulatory signal generated by the interaction of DNAM-1 
on SPMs and CD155 on T cells.
DNAM-1 on SPMs contributes to T cells proliferation in the draining lymph nodes after intra-
peritoneal immunization. To investigate whether DNAM-1 on SPMs is involved in CD4+ T cell prim-
ing in vivo, OT-II Tg mice were subjected to adoptive cell-transfer i.p. with 4 × 104 SPMs or LPMs sorted from 
WT or Cd226−/− donor mice; at the same time, immunized i.p. with TNP–OVA/Alum. On day 3, CD4+ T cells 
proliferation in the mediastinal lymph nodes (LNs, draining LNs from peritoneal cavity22) were analyzed by 
BrdU incorporation (Fig. 4A). T cells proliferation was significantly greater in SPM-transferred mice than in 
LPM-transferred mice or control mice without cell transfer (Fig. 4B,C). However, this enhanced proliferation of 
T cells was abolished in mice subjected to cell transfer with Cd266−/− SPMs (Fig. 4B,C). To confirm the involve-
ment of CD155 on T cells in CD226-mediated T cell proliferation, we used Cd155−/− OT-II mice. When WT or 
Figure 3. DNAM-1–CD155 interaction is involved in antigen presentation by SPMs. (A,B) Naïve CD4+ T cells 
isolated from OT-II Tg mice were labeled with CFSE and cocultured with SPMs isolated from WT or Cd226−/− 
mice in the presence of 1 µM pOVA. T cells proliferation was assessed by CFSE dilution as mentioned in 
Fig. 1C,D. Data are representative of four independent experiments. (C,D) Naïve CD4+ T cells were cocultured 
with WT SPMs as mentioned in (A,B). Either CD4+ T cells were pretreated with anti-CD155 mAb or SPM were 
pretreated with anti-DNAM-1. Anti-mouse CD155 mAb (TX56, rat IgG2a)19 and anti-mouse DNAM-1 mAb 
(TX42)18 were generated in our laboratory. T cells proliferation was assessed by CFSE dilution as mentioned in 
Fig. 1C,D. Data are representative of two independent experiments. Histograms show representative data (A,C) 
and bar graph shows the average of three wells after culture with pOVA (B,D). (E) After 6 days of coculture as 
mentioned in (A,B), the cells were restimulated by phorbol 12-myristate 13-acetate (PMA) and ionomycine 
for 4 hrs, then stained with anti-CD4 to distinguish CD4+ T cells with SPMs, and intracellularly stained with 
anti-IFNγ, anti-IL4 and anti-IL17 to evaluate Th differentiation of CD4+ T cells by flow cytometry analysis. Bar 
graph shows the average of three wells after culture with or without pOVA (E). Data are representative of two 
independent experiments. SEM, *P < 0.05. NS, not significant.
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Cd266−/− SPMs were transferred into Cd155−/− OT-II mice, the proliferation of both genotypes of SPM showed 
comparable (Supplementary Fig. 2). Together, these results indicate that the interaction between DNAM-1 on 
SPMs and CD155 on CD4+ T cells contributes to T cells priming in the draining lymph nodes after antigen 
immunization via the peritoneal cavity.
DNAM-1 on SPMs contributes to the germinal center reaction in mediastinal lymph nodes after 
immunization. To investigate whether DNAM-1 on SPMs affects the humoral immune response, we ana-
lyzed the GC reaction in the mediastinal lymph nodes after immunization. WT or Cd226−/− SPMs were trans-
ferred i.p. into Cd226−/− recipient mice. The mediastinal lymph nodes were harvested 7 days after immunization 
and analyzed for frequency of occurrence of GC B cells (defined as GL7+PNA+B220+ cells). The GC reaction was 
greater in SPM-transferred mice than in LPM-transferred mice or control mice without cell transfer (Fig. 5B). 
Furthermore, the enhanced GC reaction was abolished in mice that had received Cd266−/− SPMs (Fig. 5A,B). 
Together with the data in Figs 4 and 5, these results suggest that DNAM-1 expressed on SPMs in the perito-
neal cavity is involved in T cell priming and the humoral immune response in the draining lymph nodes after 
immunization.
Figure 4. DNAM-1 on SPMs contributes to T cells proliferation in mediastinal lymph nodes after 
immunization. (A–C) OT-II Tg recipient mice were transferred i.p. with 4 × 104 of LPMs or WT or Cd226−/− 
SPMs and immunized i.p. with TNP-OVA/Alum and cells proliferation were traced by injecting BrdU as 
shown in Materials and Methods. After 72 hrs, mediastinal LNs were collected; the frequencies of dividing 
CD4+ T cells were defined as the percentage of BrdU+ cells in CD3+CD4+ cells. Nuclei were stained with APC-
conjugated anti-BrdU mAb by using a BrdU Flow Kit (BD Biosciences). Schematic view of the experiment 
(A). Representative plots of BrdU staining (B). Scatter plot showing data combined from two independent 
experiments (C); SEM, *P < 0.05.
Figure 5. DNAM-1 on SPMs contributes to the GC reaction in mediastinal lymph nodes after immunization. 
(A,B) LPMs and SPMs were isolated from WT or Cd226−/− donors, and 4 × 104 cells were transferred i.p. into 
Cd226−/− recipient mice. At the same time, the recipient mice were immunized i.p. with TNP–OVA in alum 
adjuvant. Seven days after immunization, mediastinal lymph nodes were collected; the cells were stained with 
GL7 mAb, PNA, and anti-B220 mAb, and the frequencies of GC B cells (defined as the percentages of GL-
7+PNA+cells in B220+ B cells) were determined by flow cytometry. Representative plots of staining (B220+ gate) 
from SPM-transferred mice (A). The scatter plot shows data combined from four independent experiments (B) 
error bars indicate SEM. *P < 0.05. One outlier was omitted from Cd226−/−.
www.nature.com/scientificreports/
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Taken together, our results show that SPMs are functionally different from LPMs. They also show that 
DNAM-1 on SPMs plays an important role in priming T cells in the draining lymph nodes of the peritoneal cavity 
against antigens present in this cavity.
Discussion
Previous reports demonstrated that peritoneal macrophages engulf pathogens, induce neutrophils recruitment 
into the peritoneal cavity and thus play important roles in the control of infections23–25; the macrophages ana-
lyzed in these reports are likely LPMs on the basis of their surface markers. In contrast, we revealed that SPMs, 
a newly defined subset of peritoneal macrophages, but not LPMs, play an important role in adaptive immu-
nity against i.p. injected antigen. Note that SPMs are distinct from peritoneal DCs; the former have much less 
expression of CD11c and different levels of expression of CD11b and F4/803. Some reports have defined two 
populations of mouse peritoneal macrophages, MHCIIloF4/80hi and MHCIIhiF4/80lo 6,26,27. MHCIIloF4/80hi cells 
in these reports likely correspond to LPMs, considering the reported gating strategy used in the flow cytometry 
analysis. In contrast, MHCIIhiF4/80lo cells in these reports appear to be mixtures of SPMs and DCs; DCs have a 
CD11bmidMHCIIhiF4/80− phenotype (1), which is somewhat similar to the CD11b+MHCIIhiF4/80lo phenotype 
of SPMs, but DCs can be distinguished from SPMs by their stronger expression of CD11c, which was not assessed 
in these reports. Therefore, we suspect that the antigen presenting ability of MHCIIhiF4/80lo cells, which has been 
reported previously27, reflects the function of DCs. Our finding demonstrates direct evidence for the antigen 
presenting ability of SPMs.
We showed that SPMs were involved in T cell priming and GC B cell development in vivo. Because CD4+ 
helper T cells are essential for GC maintenance28, our data indicate that SPMs are involved in CD4+ T cell prolif-
eration in response to antigen immunization, which in turn enhances the humoral immune response. Given that 
peripheral tissue immunization with antigen in adjuvant induces antigen uptake by local DCs and priming of T 
cells in the draining lymph nodes29, it is speculated that SPMs take up antigen in the peritoneal cavity, migrate 
into the draining lymph nodes, and present antigen to naïve CD4+ T cells3. In support of this idea, we showed 
in this report that SPMs are able to uptake and process antigens in vivo, consistent with previous reports3,7,9. 
Moreover, Ghosn et al. reported that half of SPMs express the lymphocyte homing receptor CD62L; they also sug-
gested that SPMs migrate into lymph nodes3. Although our data suggest that SPMs migrate into the mediastinal 
lymph nodes and present antigen to T cells, further investigations are required to demonstrate the migration of 
SPMs into draining lymph nodes.
We showed here that DNAM-1 is expressed on SPMs at an exclusively high level among peritoneal mac-
rophages. A recent report by Kim et al. has demonstrated that DNAM-1 served as a distinct surface marker of 
MHCII+ resident peritoneal macrophages compared to F4/80+ counterpart30. Because MHCII+ resident perito-
neal macrophages and SPMs share MHCII molecule as a surface marker, both populations in the peritoneal cavity 
may overlap each other. More interestingly, we revealed that DNAM-1 enhances the antigen-specific CD4+ T cell 
priming by SPMs. Whereas the function of DNAM-1 as an activating receptor on T cells and NK cells had been 
well studied10–13,16–19, its function in macrophages had not yet been reported. Our report provides new under-
standing that DNAM-1 is one of the molecules characterizing particular functions of heterogeneous macrophage 
subsets.
DNAM-1-deficient SPMs showed markedly lower antigen presentation ability than WT SPMs. In addition, 
T cells proliferation was impaired when the T cells were pretreated with anti-CD155 neutralizing Ab in vitro and 
mice deficient in CD155 transferred with SPM were analyzed. Consistent with our recent findings that CD155 
mediated a costimulatory signal in naïve CD4+ T cells and induce Th1 differentiation21, these results indicate that 
interaction between DNAM-1 and its ligand, CD155, is indispensable for the function of DNAM-1 in the antigen 
presentation of SPMs. Whereas DNAM-1 acts as a signaling molecule on T cells and NK cells10,31, it is unclear 
whether DNAM-1 on SPMs mediates an activating signal in SPMs and induces changes in the function of SPMs. 
Even though we do not exclude the possibility of intracellular signaling of DNAM-1 on SPMs, our data suggest 
that DNAM-1 on SPMs interacts with CD155 expressed on CD4+ T cells, upregulates T cells proliferation and 
promotes Th1 differentiation via CD155-mediated costimulatory signals.
We propose that SPMs are functionally distinct from LPMs and that the DNAM-1–CD155 axis plays an 
important role in costimulation of antigen-specific CD4+ T cells. In this context, the exclusively high expression of 
DNAM-1 on SPMs characterizes the function of SPMs among heterogeneous subsets of peritoneal macrophages.
Methods
Mice. C57BL/6 mice were purchased from Clea Japan (Tokyo, Japan). Cd226−/− mice were generated as 
described previously18. Ovalbumin peptide (OVA323–339)-specific, MHC class II I-Ab-restricted αβ T cells recep-
tor (TCR) transgenic (OT-II Tg) mice were originally constructed as described by Barnden et al.32. Cd155−/− mice 
were kindly provided by Dr. Günter Bernhardt33. Cd155−/− OT-II mice were generated in our lab by crossing 
Cd155−/− and OT-II mice. All mice used were 8–16-week-old females or males and on the C57BL/6 background. 
All animal experiments were performed humanely after receiving approval from the Animal Ethics Committee of 
the Laboratory Animal Resource Center, University of Tsukuba, and in accordance with Fundamental Guideline 
for Proper Conduct of Animal Experiment and Related Activities in Academic Research Institutions under the 
Jurisdiction of the Ministry of Education, Culture, Sports, Science and Technology.
Flow cytometry analysis and isolation of SPMs. Peritoneal cells were harvested and then stained 
with the Abs described below: FITC-anti-mCD3 (145-2C11), CD19 (1D3), CD11c (HL3), Ly6G (1A8), and 
CD40 (HM40-3), PE-anti-mCD11b (M1/70), PE-Cy7-anti-mCD4 (RM4–5), biotin-anti-mCD80 (16-10A1), 
CD86 (PO3) mAbs, isotype-matched control Ab, PE-Cy7 and V450-streptavidin, (BD Biosciences, San Jose, 
CA, USA); Alexa647-anti-mF4/80 mAb (C1:A3-1) (AbD Serotec, Kidlington, UK); PE-Cy7-anti-mI-Ab mAb 
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(AF6–120.1) (BioLegend, San Diego, CA, USA); and anti-mDNAM-1 mAb (Clone, TX42. Isotype, rIgG2a) 
generated in our laboratory18 and conjugated with biotin; for intracellular staining, PE-anti-mIL4 (11B11) and 
Alexa647-anti-mIL17 (TC-11–18H10) (BD Biosciences) and FITC-anti-mIFNγ (XMG1.2) (TONBO Biosciences, 
San Diego, CA, USA) mAbs.
Propidium iodide was used to identify and exclude dead cells. Sample acquisition was performed by using a 
FACSCallibur or FACSFortessa cell analyzer (BD Biosciences). FlowJo software (Tree Star, Ashland, OR, USA) 
was used for data analysis. LPMs and SPMs were sorted on a FACSAria sorter (BD Biosciences).
Isolation of naïve CD4+ T cells. CD4+ T cells were isolated from the spleens of OT-II Tg mice by using 
anti-mCD4 MACS technology (Miltenyi Biotec, Auburn, CA, USA) according to the manufacturer’s instructions. 
Cells were stained with PE-Cy7-anti-mCD4 (RM4–5), allophycocyanin (APC)-anti-mCD62L (MEL-14), and 
APC-Cy7-anti-m/hCD44 (IM7) mAbs (BD Biosciences), and CD62LhiCD44dullCD4+ naïve T cells were sorted by 
using a FACSAria cell sorter.
T cell proliferation assay. Isolated naïve CD4+ T cells were labeled with CFSE. T cells (2 × 104 cells) were 
cocultured with the same number of LPMs or SPMs in the presence of 0.25, 0.5, or 1 µM of OVA323–339 peptide 
(pOVA). On day 5, cells were stained with PE-conjugated anti-mouse CD11b mAb, and then CFSE dilution was 
measured by using a FACSCalibur cell analyzer (BD Bioscience).
Immunization and cell transfer assay. For conjugating with trinitrophenyl (TNP), OVA (Sigma-Aldrich, 
St. Louis, USA) was incubated with picrylsulfonic acid (pH 8.5) overnight at 4 °C and then dialyzed with PBS; the 
average number of TNP per OVA molecule was 7.9. Mice were immunized i.p. with 35 µg of TNP–OVA emulsified 
with 100 µl of 2% alum adjuvant (InvivoGen, San Diego, CA, USA) (TNP-OVA/Alum). For the in vivo prolifera-
tion assay, the mice were injected i.p. with 200 µl of 10 mg/ml 5-bromo-2′-deoxyuridine (BrdU) in saline (2 mg) at 
24, 48, and 60 h after immunization. For germinal center (GC) staining, mediastinal lymph nodes were collected 
7 days after immunization; cells were stained with PE-conjugated anti-mouse B220, Alexa647-conjugated GL7 
mAb (BD Biosciences), and biotinylated peanut agglutinin (PNA; Vector Laboratories, Burlingame, CA), fol-
lowed by FITC-conjugated streptavidin. Cells were analyzed with a FACSCalibur cell analyzer (BD Biosciences).
Phagocytosis assay. Mice were i.p. injected with 200 μg of pHrodo Red-conjugated Staphylococcus aureus 
(A10010, Invitrogen, Carlsbad, CA, United States). Two hours later, peritoneal cells were collected and SPMs, 
which was identified as Zombie−, Lin (CD3, CD19, CD11c, Ly6G, and Ly6C)−, CD11bhi, F4/80lo cells, were ana-
lyzed for pHrodo fluorescence by flow cytometry (FACSAria Special Order Research Products (SORP) sorter (BD 
Biosciences)).
Antigen processing assay. One hundred μg of BODIPY-labelled dye quenching Ovalbumin (DQ-OVA, 
D12053, Invitrogen, Carlsbad, CA, United States) emulsified with 100 µl of 2% alum adjuvant was i.p. injected 
into mice. One hour later, peritoneal cells were collected and SPMs, which was identified as described above, were 
analyzed for a green fluorescence derived from digestion products by flow cytometry (FACSAria Special Order 
Research Products (SORP) sorter (BD Biosciences)).
In vitro IL-12 production. Isolated naïve CD4+ T cells (2 × 104 cells) were cocultured with the same num-
ber of SPMs in the presence of 1 µM of pOVA. At 0, 20 and 40 h, the culture supernatant was measured for IL-12 
content by ELISA.
Statistical analysis. Statistical analyses were performed by using the unpaired two-sided Student’s t-test 
(GraphPad Prism  7, GraphPad Software, La Jolla, USA). P values (P) less than 0.05 were considered statistically 
significant.
Data Availability Statement
No datasets were generated or analysed during the current study.
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